AzTrials
AzTrials

Dental CariesNCT06496126

Clinical Comparison of Resin-hybrid Ceramic Restorations Produced Using a Computer-aided Design/Computer-aided Manufacturing (CAD/CAM) System With Fiber-reinforced Composite Restorations

A study testing Cerasmart 270 (GC Coop, Tokyo, Japonya), EverX Flow (GC Coop, Tokyo, Japonya) and : G-CEM ONE (GC Coop, Tokyo, Japonya) in people with Dental Caries, run by Hacettepe University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this clinical study was to compare the clinical performance of CAD/CAM endochrone and fibre-reinforced composite restorations in root canal treated teeth with excessive loss. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Dental Caries
What is being tested?
Cerasmart 270 (GC Coop, Tokyo, Japonya), EverX Flow (GC Coop, Tokyo, Japonya) and : G-CEM ONE (GC Coop, Tokyo, Japonya)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 siteTurkey (Türkiye)
Study dates
12 Jan 2023to 12 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy individuals without any systemic disease
  • Those between the ages of 18-65
  • Individuals who brush their teeth twice a day
  • Patients with at least 1 root canal treatment, loss of one or more tubercles and loss of at least 1 tooth wall in their posterior teeth after intraoral examination
  • Tooth margins at gingival or supramarginal level
  • Patients whose periodontal and endodontic treatments have been successfully completed and who do not show any subjective symptoms
Show all 9Show fewer
  • Voluntary individuals who agree to participate in the study and sign the informed consent form will be included in the study.
  • Patients will be informed about the study, read the informed consent form and agree to be included in the study.
  • Ability to apply rubber cover

Who cannot join

  • Individuals with uncontrolled systemic diseases
  • Individuals with mental retardation who cannot co-operate
  • Individuals with advanced periodontal disease
  • Individuals using removable partial dentures
  • Toothache, inadequate endodontic treatment or signs of periapical lesions on clinical examination or radiographic examination
  • Vital teeth
Show all 10Show fewer
  • Individuals with bruxism
  • Individuals with malocclusion
  • Teeth with severe loss of material that requires extraction of the relevant tooth
  • Patients read the informed consent form following the information about the study and did not agree to be included in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Hacettepe University

    Ankara, 06100

Other trials in Turkey (Türkiye)

About this study

The aim of this clinical study was to compare the clinical performance of CAD/CAM endochrone and fibre-reinforced composite restorations in root canal treated teeth with excessive loss.

Read the detailed description

Restoration of endodontically treated teeth is one of the significant challenges encountered in dentistry. The restoration of these teeth is often confronted with a series of complex factors. Following endodontic treatment, the coronal structure of the tooth may have been significantly weakened or lost. This condition makes it difficult to properly place restorative materials and restore the tooth's durability. Additionally, the weakness or loss of coronal structure after root canal treatment makes it difficult for these teeth to perform their normal functions and withstand chewing forces. Consequently, the restoration of endodontically treated teeth is a process that requires careful planning by dentists, selection of appropriate materials, and implementation of suitable techniques.

Endocrown restorations and fiber-reinforced composites (e.g., EverX Flow) are commonly used options in the restoration of such teeth. Endocrown restorations help support the tooth by covering a significant portion of the coronal structure.

GC Cerasmart 270 (GC Corporation, Tokyo, Japan) is a resin nanoceramic structure containing approximately 71% (by weight) of nanoceramic particles bonded to a resin matrix. Restorations designed digitally can be milled from a milling device for use in the production of restorations. With its enhanced strength and wear resistance, smooth restorations can be produced, limiting both aesthetic appearance and wear of opposing teeth.

Fiber-reinforced composites contain glass fibers to increase durability, thereby reducing the fragility of teeth after root canal treatment and aiding in preventing cracks. EverX Flow is a flowable composite reinforced with short fibers indicated for dentin replacement (along with a traditional composite as the enamel layer) in direct restorations and core build-ups. Due to its short fibers, EverX Flow efficiently strengthens restorations and demonstrates high fracture resistance.

In each patient, one or more endodontically treated teeth will be randomly assigned to be restored using either GC Cerasmart 270 blocks or EverX Flow (combined with GC Achord). GC Cem One Resin Cement will be used for adhesive procedures in the endocrown group, while GC G-Premio Bond will be used in the fiber composite group. Restoration procedures will be performed by a single operator. Restorations will be evaluated by two calibrated evaluators according to modified USPHS criteria at baseline and at 6 and 12 months. Data will be statistically analyzed using chi-square Cochrane and McNemar tests (p <0.05).

Conditions
Dental Caries
Being tested
Cerasmart 270 (GC Coop, Tokyo, Japonya), EverX Flow (GC Coop, Tokyo, Japonya), : G-CEM ONE (GC Coop, Tokyo, Japonya), G-Premio Bond (GC Coop, Tokyo, Japonya), G-ænial A'CHORD
Keywords
CAD/CAM, Endocrown, Fiber-reinforced composite
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cerasmart 270 (GC Coop, Tokyo, Japonya)Device

    Hybrid Ceramic Block

  • EverX Flow (GC Coop, Tokyo, Japonya)Device

    Fiber Reinforced Composite Resin

  • : G-CEM ONE (GC Coop, Tokyo, Japonya)Device

    Universal Self Adhesive Resin Cement

  • G-Premio Bond (GC Coop, Tokyo, Japonya)Device

    Universal Adhesive

  • G-ænial A'CHORDDevice

    Conventional Composite Resin

Study groups in NCT06496126
Study groupRoleWhat they receive
Cerasmart 270 (GC Coop, Tokyo, Japonya)ExperimentalComposition: Bis-MEPP, UDMA, dimethacrylate, silica (20 nm), barium glass (300 nm) 71 wt% Tooth measurement and digital design are done using a camera. The design is sent to a milling device for restoration fabrication. Tooth surface is roughened with 37% orthophosphoric acid for 10 seconds, air dried, and Adhesive Primer is applied. Inner surface of the endocrown restoration is sandblasted with aluminum oxide powder, cleaned with alcohol, and coated with Adhesive Primer. CEM ONE self-adhesive resin cement is applied to the tooth surface, and the restoration is cemented.Final polymerization process lasts 10 seconds per surface to ensure bonding.Rough edges of the restoration are polished with diamond burs and discs. Excess material is removed, and occlusion and tooth areas are checked.Any cement residues in the mouth are carefully cleaned.
Receives: Device: Cerasmart 270 (GC Coop, Tokyo, Japonya); Device: : G-CEM ONE (GC Coop, Tokyo, Japonya)
EverX Flow (GC Coop, Tokyo, Japonya)ExperimentalResin: semi-IPN matrix composed of Bis-GMA, TEGDMA and PMMA. Fillers: E-glass fiber, barium borosilicate (57 vol%) After cavity preparation, 37% phosphoric acid gel will be applied to the enamel for 30 seconds, washed with water and dried slightly. G-Premio Bond adhesive agent (GC, Tokyo, Japan) is applied to the enamel and dentin surfaces with a disposable applicator for 20 seconds and waited for 10 seconds according to the manufacturer's recommendations. Then, air is squeezed with light air pressure for 5 seconds and polymerised with LED light at 1200 mW/cm2 for 10 seconds. The restoration walls are formed with composite G-ænial™ A'CHORD (GC, Tokyo, Japan). EverX Flow composite (GC, Tokyo, Japan) is applied to the cavities in 4 mm layers and polymerised with light for 10 seconds. G-ænial™ A'CHORD (GC, Tokyo, Japan) composite is applied on the top layer. It is shaped with finishing cutters and polished with polishing rubbers.
Receives: Device: EverX Flow (GC Coop, Tokyo, Japonya); Device: G-Premio Bond (GC Coop, Tokyo, Japonya); Device: G-ænial A'CHORD

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retention

    Observers evaluated the restorations was performed using the United State Public Health Service criteria regarding retention rate. Retention rate was evaluated by 2 independent clinicians. Scores: Alfa: No loss of restorations materyal.

    Charlie: Any loss of restorative material

    Measured: [Time Frame: From baseline to 24 month]

  2. Marginal discoloration

    Observers evaluated the restorations was performed using the modified United State Public Health Service criteria regarding Marginal staining. Marginal staining was evaluated by 2 independent clinicians. Visual inspection with a mirror was performed. Scorsese: Alfa: No discoloration. Bravo: Discoloration without. Charlie:Discoloration with penetration in pulpal direction

    Measured: [Time Frame: From baseline to 24 month]

  3. Marginal Adaptation

    Observers evaluated the restorations was performed using the modified United State Public Health Service criteria regarding marginal adaptation. Marginal adaptation was evaluated by 2 independent clinicians. Visual inspection with a mirror was performed. Scores; Alfa: Closely adapted, no visible crevice. Bravo: Visible crevice, explorer will penetrate.

    Charlie: Crevice in which dentin is exposed

    Measured: [Time Frame: From baseline to 24 month]

  4. Seconder Caries

    Observers evaluated the restorations was performed using the United State Public Health Service criteria regarding retention rate. Retention rate was evaluated by 2 independent clinicians. Scores: Alfa: No caries presented. Charlie Caries present

    Measured: [Time Frame: From baseline to 24 month]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2024
  2. Study start12 Jan 2023
  3. Primary completion12 Jun 2024
  4. Study completion12 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06496126
Sponsor's protocol ID
KA-23074
Status last verified
Jul 2024
First submitted
26 Jun 2024
Last updated
11 Jul 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Bijelic-Donova J, Myyrylainen T, Karsila V, Vallittu PK, Tanner J. Direct Short-Fiber Reinforced Composite Resin Restorations and Glass-Ceramic Endocrowns in Endodontically Treated Molars: A 4 -Year Clinical Study. Eur J Prosthodont Restor Dent. 2022 Nov 30;30(4):284-295. doi: 10.1922/EJPRD_2333Bijelic-Donova12.

    PubMed 35438265
  • Soares LM, Razaghy M, Magne P. Optimization of large MOD restorations: Composite resin inlays vs. short fiber-reinforced direct restorations. Dent Mater. 2018 Apr;34(4):587-597. doi: 10.1016/j.dental.2018.01.004. Epub 2018 Jan 20.

    PubMed 29366492

Questions about this trial

What is this clinical trial studying?

A study testing Cerasmart 270 (GC Coop, Tokyo, Japonya), EverX Flow (GC Coop, Tokyo, Japonya) and : G-CEM ONE (GC Coop, Tokyo, Japonya) in people with Dental Caries, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retention (time frame: [Time Frame: From baseline to 24 month]). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06496126, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in